CVE-2013-3995
Cross-site scripting (XSS) vulnerability in IBM InfoSphere BigInsights 1.1 through 2.1 allows...
Cross-site scripting (XSS) vulnerability in IBM InfoSphere BigInsights 1.1 through 2.1 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors.
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in IBM InfoSphere BigInsights 1.1 through 2.1 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors.
- Record
CVE-2013-3995- CVSS 2.0
- 3.5 Low
AV:N/AC:M/Au:S/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in IBM InfoSphere BigInsights 1.1 through 2.1 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors.
- Record
CVE-2013-3995- Updated
- 2026-11-02
EUVDEUVD-2013-3927 No score
Cross-site scripting (XSS) vulnerability in IBM InfoSphere BigInsights 1.1 through 2.1 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors.
- Record
EUVD-2013-3927- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-96h6-4894-p3mr No score
Cross-site scripting (XSS) vulnerability in IBM InfoSphere BigInsights 1.1 through 2.1 allows...
Cross-site scripting (XSS) vulnerability in IBM InfoSphere BigInsights 1.1 through 2.1 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors.
- Record
GHSA-96h6-4894-p3mr- Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2013-3995 is a low vulnerability (CVSS 3.5) in Ibm Infosphere Biginsights, published August 5, 2013. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.95%, the 61st percentile. No source names a fixed version.